Emergent BioSolutions CEO Presents at H.C. Wainwright Conference

What Happened
On September 14, 2026, Emergent BioSolutions Inc. filed a Form 8‑K (Regulation FD disclosure) reporting that President and CEO Joseph C. Papa will present at the H.C. Wainwright 28th Annual Global Investment Conference. The slides to be used in the presentation are furnished as Exhibit 99.1 to the 8‑K and are incorporated by reference.

Key Details

• Filing date: September 14, 2026 (Form 8‑K, Item 7.01 – Regulation FD Disclosure).
• Presenter: Joseph C. Papa, President and Chief Executive Officer.
• Event: H.C. Wainwright 28th Annual Global Investment Conference (presentation on Sept 14, 2026).
• Exhibit: Investor presentation slides furnished as Exhibit 99.1; filing signed by Richard S. Lindahl, EVP & CFO.

Why It Matters
This 8‑K makes management’s investor presentation public under Regulation FD, giving all investors access to the same slides Mr. Papa will use at the conference. The filing does not include earnings, financial results, executive changes, mergers, or other material agreements — it is a disclosure of a scheduled investor presentation and the related slides. Investors can review Exhibit 99.1 for any updates or commentary management provides at the conference.